共 50 条
- [31] Autophagy modulates glioblastoma cell sensitivity to Selinexor-mediated XPO1 inhibitionNEURO-ONCOLOGY, 2025,Tang, YongjianSprinzen, LisaTerada, YukinoriKiang, Karrie M.Li, ChuntaoZeng, YuLiu, FangkunZhou, HongshuLiang, XisongZhang, JianzhongPieper, Russell O.Chen, BoZhang, Liyang
- [32] Inhibiting the Nuclear Exporter XPO1 and the Antiapoptotic Factor BCL2 Is Synergistic in XPO1 Mutant and Wildtype LymphomaBLOOD, 2020, 136Owusu-Ansah, FrankAfaghani, JumanaLee, StanleyTaylor, Justin
- [33] Clinicopathological and prognostic significance of XPO1 in solid tumors: meta-analysis and TCGA analysisEXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2023, 23 (07) : 607 - 618Tan, YangChen, GangHe, Rong-QuanHuang, Zhi-GuangDang, Yi-WuLuo, Jia-YuanHuang, Wan-YingHuang, Su-NingLiu, RunFeng, Zhen-Bo
- [34] Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AMLBLOOD ADVANCES, 2022, 6 (22) : 5938 - 5949Pianigiani, GiuliaGagliardi, AndreaMezzasoma, FedericaRocchio, FrancescaTini, ValentinaBigerna, BarbaraSportoletti, PaoloCaruso, SimonaMarra, AndreaPeruzzi, SaraPetito, EleonoraSpinozzi, GiulioShacham, SharonLandesman, YosefQuintarelli, ConcettaGresele, PaoloLocatelli, FrancoBrunetti, LorenzoMartelli, Maria PaolaFalini, Brunangelo
- [35] The Synergistic Effect of Melphalan and XPO1 Inhibition in Pre-Clinical Models of Multiple MyelomaBLOOD, 2016, 128 (22)Cui, YanTurner, Joel G.Dawson, Jana L.Gomez, Juan A.Shain, Kenneth H.Meads, Mark B.Baloglu, ErkanDalton, William S.Nishihori, TaigaSullivan, Daniel M.
- [36] FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical modelsBIOCHEMICAL PHARMACOLOGY, 2018, 147 : 93 - 103Corno, CristinaStucchi, SimoneDe Cesare, MichelandreaCarenini, NivesStamatakos, SerenaCiusani, EmilioMinoli, LuciaScanziani, EugenioArgueta, ChristianLandesman, YosefZaffaroni, NadiaGatti, LauraPerego, Paola
- [37] SELINEXOR Exportin-1(XPO1) inhibitor OncolyticDRUGS OF THE FUTURE, 2014, 39 (10) : 685 - 692Riaz, W.Burke, N.Mahipal, A.
- [38] XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5ACLINICAL CANCER RESEARCH, 2015, 21 (14) : 3286 - 3297Miyake, TakahitoPradeep, SunilaWu, Sherry Y.Rupaimoole, RajeshaZand, BehrouzWen, YunfeiGharpure, Kshipra M.Nagaraja, Archana S.Hu, WeiCho, Min SoonDalton, Heather J.Previs, Rebecca A.Taylor, Morgan L.Hisamatsu, TakeshiKang, YuLiu, TaoShacham, SharonMcCauley, DilaraHawke, David H.Wiktorowicz, John E.Coleman, Robert L.Sood, Anil K.
- [39] Targeting metabolic vulnerabilities of endocrine resistant breast cancers using XPO1 and NAMPT inhibition.CANCER RESEARCH, 2021, 81 (13)Zuo, QianyingMogol, AycaImir, OzanLandesman, YosefErdogan, Zeynep Madak
- [40] Inhibition Of Nuclear Transport Modulator Xpo1/CRM1 For The Treatment Of Acute Myeloid Leukemia (AML)BLOOD, 2013, 122 (21)Rettig, Michael P.Holt, MatthewPrior, JulieShacham, SharonKauffman, MichaelMcCauley, DilaraDipersio, John F.